Luping Qiu - Concepedia

Author

Luping Qiu

Pfizer (United States)

Also Known As

L Qiu, L. QIU, Luping Qiu, Qiu, Luping

Publications

431

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

Luping Qiu is an author at Pfizer (United States) specializing in medicine, cell biology, and cell engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	170
2	Cell Biology	2	2	138
3	Engineering	1	1	115
4	Biomedical Engineering	1	1	115
5	Biomolecular Engineering	1	1	23

Luping Qiu

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Broad‐spectrum matrix metalloproteinase inhibitor marimastat–induced musculoskeletal side effects in rats Richard R. Renkiewicz, Luping Qiu, Charles A. Lesch, Arthritis & Rheumatism	2003	170
Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo Vijaykumar M. Baragi, Richard R. Renkiewicz, Luping Qiu, Osteoarthritis and Cartilage Tissue EngineeringEngineeringBone RepairTissue TransplantationBiomedical Engineering	1997	115
Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3‐3p21.3 in sporadic breast‐cancer development Dorothy L. Buchhagen, Luping Qiu, Polly R. Etkind International Journal of Cancer	1994	49
Utilization of Causal Reasoning of Hepatic Gene Expression in Rats to Identify Molecular Pathways of Idiosyncratic Drug-Induced Liver Injury Daphna Laifenfeld, Luping Qiu, Rachel Swiss, Toxicological Sciences Mitochondrial DysfunctionPathologyToxicological MechanismOxidative StressHepatotoxicity	2013	32
Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers Luping Qiu, Kymberly K. Levine, K.S. Gajiwala, PLoS ONE Small Molecule InhibitorsBreast OncologyKinase InhibitorsBreast CancersCancer Biology	2018	23
Quantitative systems toxicology (QST) reproduces species differences in PF‐04895162 liver safety due to combined mitochondrial and bile acid toxicity Grant T. Generaux, Vinal Lakhani, Yuching Yang, Pharmacology Research & Perspectives	2019	22
High-Content Imaging in Human and Rat Hepatocytes Using the Fluorescent Dyes CLF and CMFDA Is Not Specific Enough to Assess BSEP/Bsep and/or MRP2/Mrp2 Inhibition by Cholestatic Drugs Luping Qiu, James E. Finley, Mohammed Taimi, Applied In Vitro Toxicology	2015	10

Page 1